X-FAB Silicon Foundries (XFAB) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
18 Aug, 2026Executive summary
Q2 2025 revenue ranged from $215 million to $218.3 million, up 5–8% year-over-year and quarter-over-quarter, with core markets (automotive, industrial, medical) contributing up to 94% of total revenue and strong growth in industrial and medical segments.
Bookings increased 19% sequentially to $207.2 million, with backlog rising to $413 million, indicating robust demand and two consecutive quarters of order intake growth.
Completion of a three-year capacity expansion program, including a new clean room in Malaysia, positions the business for further growth.
Key growth drivers included EV-related automotive applications, power management for data centers, and medical-grade contactless temperature sensors.
Financial highlights
Q2 2025 EBITDA was $51.6 million (24% margin), gross profit was $49.9 million (23.2% margin), and EBIT was $21.7 million (10.1% margin); net profit was -$0.4 million due to a $17.4 million unrealized FX loss.
Q2 CapEx was $53.7–$54 million; H1 2025 CapEx totaled $155–$155.5 million, with full-year CapEx guidance at $250 million.
Cash and cash equivalents at quarter-end were $157.7 million, nearly unchanged sequentially.
Net debt increased to $310.4 million as of June 30, 2025, from -$19.2 million a year earlier.
Outlook and guidance
Full-year 2025 revenue guidance upgraded to $840–$870 million, with EBITDA margin expected between 24% and 27%.
Q3 2025 revenue expected at $215–$225 million, with EBITDA margin of 22.5%–25.5%.
Gradual revenue growth and improved profitability anticipated as capacity expansion normalizes.
Latest events from X-FAB Silicon Foundries
- Q2 2026 revenue fell up to 10% YoY, but bookings and medical growth signal recovery.XFAB
Q2 2026 - Q1 2026 revenue was $195.6M, with strong growth in industrial, medical, and microsystems.XFAB
Q1 2026 - Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 2025 - Q3 2025 revenue up 12% YoY to $229M, led by industrial and medical growth; order intake fell.XFAB
Q3 2025 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
Investor Day 2025 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 2024 - Q3 revenue up sequentially, automotive strong, industrial/medical weak, guidance lowered.XFAB
Q3 2024 - Q2 revenue fell 9% year-on-year; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 2024 - Q4 2024 revenue and profit fell amid auto destocking; CapEx to drop and recovery expected in 2025.XFAB
Q4 2024